The prices of targeted drugs for lung cancer are related to patients’ geographical location, hospital level and drug use, and are not static. Clinically used targeted drugs include gefitinib, erlotinib, erlotinib, ositinib, etc. Among them, the price of erlotinib is about RMB1400 per box; the price of domestic version of gefitinib is less than RMB2000 per box, while the price of imported version is higher than RMB2000 per box. Lung cancer patients are recommended to choose suitable targeted drugs under the guidance of comprehensive analysis by professional oncologists.